This news feature discusses advancements in cancer diagnostics that make early detection of recurrence possible through cutting-edge liquid biopsy techniques. Dr. Jayant Khandare explains how circulating tumor cell–based testing can help monitor disease progression, guide treatment decisions, and improve patient outcomes. The report emphasizes the growing cancer burden and the importance of accessible, minimally invasive diagnostic solutions in India.